283 related articles for article (PubMed ID: 18599553)
1. Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors.
Morfis M; Tilakaratne N; Furness SG; Christopoulos G; Werry TD; Christopoulos A; Sexton PM
Endocrinology; 2008 Nov; 149(11):5423-31. PubMed ID: 18599553
[TBL] [Abstract][Full Text] [Related]
2. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
Udawela M; Christopoulos G; Morfis M; Tilakaratne N; Christopoulos A; Sexton PM
Regul Pept; 2008 Jan; 145(1-3):65-71. PubMed ID: 17884192
[TBL] [Abstract][Full Text] [Related]
3. A critical role for the short intracellular C terminus in receptor activity-modifying protein function.
Udawela M; Christopoulos G; Morfis M; Christopoulos A; Ye S; Tilakaratne N; Sexton PM
Mol Pharmacol; 2006 Nov; 70(5):1750-60. PubMed ID: 16912219
[TBL] [Abstract][Full Text] [Related]
4. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.
Christopoulos G; Perry KJ; Morfis M; Tilakaratne N; Gao Y; Fraser NJ; Main MJ; Foord SM; Sexton PM
Mol Pharmacol; 1999 Jul; 56(1):235-42. PubMed ID: 10385705
[TBL] [Abstract][Full Text] [Related]
5. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.
Zumpe ET; Tilakaratne N; Fraser NJ; Christopoulos G; Foord SM; Sexton PM
Biochem Biophys Res Commun; 2000 Jan; 267(1):368-72. PubMed ID: 10623626
[TBL] [Abstract][Full Text] [Related]
6. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors.
Udawela M; Christopoulos G; Tilakaratne N; Christopoulos A; Albiston A; Sexton PM
Mol Pharmacol; 2006 Jun; 69(6):1984-9. PubMed ID: 16531504
[TBL] [Abstract][Full Text] [Related]
7. Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.
Tilakaratne N; Christopoulos G; Zumpe ET; Foord SM; Sexton PM
J Pharmacol Exp Ther; 2000 Jul; 294(1):61-72. PubMed ID: 10871296
[TBL] [Abstract][Full Text] [Related]
8. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
9. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3.
Muff R; Bühlmann N; Fischer JA; Born W
Endocrinology; 1999 Jun; 140(6):2924-7. PubMed ID: 10342886
[TBL] [Abstract][Full Text] [Related]
10. Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line.
Perry KJ; Quiza M; Myers DE; Morfis M; Christopoulos G; Sexton PM
Endocrinology; 1997 Aug; 138(8):3486-96. PubMed ID: 9231803
[TBL] [Abstract][Full Text] [Related]
11. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins.
Kikumoto K; Katafuchi T; Minamino N
Hypertens Res; 2003 Feb; 26 Suppl():S15-23. PubMed ID: 12630807
[TBL] [Abstract][Full Text] [Related]
12. Receptors for calcitonin gene-related peptide, adrenomedullin, and amylin: the contributions of novel receptor-activity-modifying proteins.
Born W; Fischer JA; Muff R
Recept Channels; 2002; 8(3-4):201-9. PubMed ID: 12529937
[TBL] [Abstract][Full Text] [Related]
13. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
[TBL] [Abstract][Full Text] [Related]
14. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor.
Armour SL; Foord S; Kenakin T; Chen WJ
J Pharmacol Toxicol Methods; 1999 Dec; 42(4):217-24. PubMed ID: 11033437
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.
Lee SM; Hay DL; Pioszak AA
J Biol Chem; 2016 Apr; 291(16):8686-700. PubMed ID: 26895962
[TBL] [Abstract][Full Text] [Related]
17. Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs).
Fischer JA; Muff R; Born W
Biochem Soc Trans; 2002 Aug; 30(4):455-60. PubMed ID: 12196114
[TBL] [Abstract][Full Text] [Related]
18. Novel calcitonin-(8-32)-sensitive adrenomedullin receptors derived from co-expression of calcitonin receptor with receptor activity-modifying proteins.
Kuwasako K; Kitamura K; Nagoshi Y; Eto T
Biochem Biophys Res Commun; 2003 Feb; 301(2):460-4. PubMed ID: 12565884
[TBL] [Abstract][Full Text] [Related]
19. Adrenomedullin and related peptides: receptors and accessory proteins.
Muff R; Born W; Fischer JA
Peptides; 2001 Nov; 22(11):1765-72. PubMed ID: 11754962
[TBL] [Abstract][Full Text] [Related]
20. Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors.
Gingell JJ; Burns ER; Hay DL
Endocrinology; 2014 Jan; 155(1):21-6. PubMed ID: 24169554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
